Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days): Full Scheme Comparison and Current Status

August 5, 2026
Posted by: Ankit Jaiswal
Category: Mutual Funds

Nippon India Capital Builder Fund IV Series A last NAV Around Rs 10.33. UTI Focussed Equity Fund Series – 1 (2195 Days) NAV and AUM not publicly available for this specific option.

The Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison matters for investors who came across these two close ended equity schemes while researching older mutual fund NFOs and want to know where they stand today. Both funds were structured with a fixed tenure at launch but follow different investment themes. This Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) breakdown covers category, structure, available data and present day investability of each scheme.

Click Here – Get Free Investment Predictions

Table of Contents

Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days): Quick Comparison at a Glance

This Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) table lays out the core facts side by side so you can see how the two close ended funds differ on structure, theme and scale.

Parameter	Nippon India Capital Builder Fund IV Series A	UTI Focussed Equity Fund Series – 1 (2195 Days)
AMC	Nippon India Mutual Fund	UTI Mutual Fund
Category	Close Ended Equity, Multi Cap	Close ended equity scheme with a tenure fixed at launch, as indicated by the day count in the scheme name
Launch / Era	Launched 23 October 2017	This series belongs to a family of nfos uti mutual fund launched from 2014 onward, a period when uti’s close ended equity nfos were mobilising several hundred crore each
Benchmark	Nifty 500 TRI (indicative for multi cap category)	Not confirmed in public trackers for this Series
Risk Level	Moderately High	Very High (typical for this category)
Last Available NAV	Around Rs 10.33 (Direct Growth, NAV as of October 2020)	Not publicly available for this specific option
AUM Last Reported	Approx Rs 145 Cr (Regular Plan, last reported)	Not publicly available for this specific option
Current Status	Close ended equity scheme launched October 2017; public NAV tracking thins out after October 2020, consistent with scheme maturity on the fixed tenure date	Close ended with a fixed day count tenure; most series in this family would have matured several years after their launch

About Nippon India Capital Builder Fund IV Series A

In this Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison, Nippon India Capital Builder Fund IV Series A is a close ended equity, multi cap scheme from Nippon India Mutual Fund. Launched 23 October 2017, benchmarked against the Nifty 500 TRI (indicative for multi cap category). Close ended equity scheme launched October 2017; public NAV tracking thins out after October 2020, consistent with scheme maturity on the fixed tenure date. That structure is the Kotak side of the Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison.

About UTI Focussed Equity Fund Series – 1 (2195 Days)

The other half of this Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison, UTI Focussed Equity Fund Series – 1 (2195 Days), is a focused high conviction equity close ended equity scheme with a tenure fixed at launch, as indicated by the day count in the scheme name from UTI Mutual Fund. This series belongs to a family of nfos uti mutual fund launched from 2014 onward, a period when uti’s close ended equity nfos were mobilising several hundred crore each. Close ended with a fixed day count tenure; most series in this family would have matured several years after their launch. That is the UTI side of the Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison.

Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days): Key Differences Explained

The points below summarise what the Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison shows once you move past scheme names and into structure.

Investment theme: Nippon India Capital Builder Fund IV Series A follows a close ended equity, multi cap mandate, while UTI Focussed Equity Fund Series – 1 (2195 Days) is built around focused high conviction equity, which is a different risk and return profile.
AMC: Nippon India Capital Builder Fund IV Series A comes from Nippon India Mutual Fund, while UTI Focussed Equity Fund Series – 1 (2195 Days) comes from UTI Mutual Fund, so expense structures, fund management style and distribution reach differ.
Structure: Close ended equity scheme launched October 2017; public NAV tracking thins out after October 2020, consistent with scheme maturity on the fixed tenure date By comparison, close ended with a fixed day count tenure; most Series in this family would have matured several years after their launch
Overall takeaway: the Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison ultimately comes down to two different close ended strategies from different fund houses, and neither accepts fresh investment today.

These structural differences sit at the centre of any Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison and matter more than any single data point.

Check the Univest Screener for live fund and stock data

Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days): Are These Schemes Still Open for Fresh Investment

Both schemes in this Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison were structured as close ended funds with a fixed tenure, which means neither accepts fresh lumpsum or SIP investment once the original NFO window closes. Investors who already hold units generally have to wait for maturity or a scheme merger to access their money. For Nippon India Capital Builder Fund IV Series A, close ended equity scheme launched october 2017; public nav tracking thins out after october 2020, consistent with scheme maturity on the fixed tenure date. For UTI Focussed Equity Fund Series – 1 (2195 Days), close ended with a fixed day count tenure; most Series in this family would have matured several years after their launch. Investors seeking similar exposure today can look at UTI Mutual Fund’s current open ended equity schemes, which is the practical takeaway from this Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) status check.

Download the Univest iOS App or Univest Android App to track live NAV updates and screen mutual fund data on the go.

Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days): Which One Fits Your Portfolio

Since both schemes are close ended and not confirmed open for fresh investment, this Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison is most useful for existing unit holders trying to understand their scheme’s positioning. This Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) guidance section exists for that reason. Investors who already hold either scheme should track maturity dates, merger announcements or IDCW payouts through their AMC’s official communication and consolidated account statements, since specific NAV and AUM for UTI Focussed Equity Fund Series – 1 (2195 Days) were not publicly available for this analysis. That is the core practical lesson of this Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison, and it is always worth confirming details with a SEBI registered advisor before deciding.

Conclusion

The Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison shows two different close ended equity strategies, one from Nippon India Mutual Fund and the other from UTI Mutual Fund. Neither scheme is confirmed open for fresh investment today. This Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) review is a reminder to check AMC statements for the latest status on any holding. New investors exploring similar strategies should look at current open ended schemes from Nippon India Mutual Fund and UTI Mutual Fund and consult a SEBI registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days)

The common questions readers ask about the Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison are answered below.

Is Nippon India Capital Builder Fund IV Series A open for fresh investment right now?

Ans. No. In the Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison, Nippon India Capital Builder Fund IV Series A is the close ended scheme from Nippon India Mutual Fund. Close ended equity scheme launched October 2017; public NAV tracking thins out after October 2020, consistent with scheme maturity on the fixed tenure date.

Is UTI Focussed Equity Fund Series – 1 (2195 Days) still open for investment today?

Ans. In the Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison, UTI Focussed Equity Fund Series – 1 (2195 Days) is a close ended equity scheme with a tenure fixed at launch, as indicated by the day count in the scheme name. Close ended with a fixed day count tenure; most series in this family would have matured several years after their launch, so specific current NAV and AUM data are not publicly available.

What is the single biggest difference highlighted in the Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison?

Ans. The biggest difference in the Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison is investment theme. Nippon India Capital Builder Fund IV Series A follows a close ended equity, multi cap mandate, while UTI Focussed Equity Fund Series – 1 (2195 Days) is built around focused high conviction equity.

Which AMC manages each fund in this Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison?

Ans. Nippon India Capital Builder Fund IV Series A is managed by Nippon India Mutual Fund, and UTI Focussed Equity Fund Series – 1 (2195 Days) is managed by UTI Mutual Fund.

What should existing investors take away from the Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison?

Ans. Existing investors reading this Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison should refer to their AMC statements and any maturity or merger notice for the current status of their holding.

Is there an open ended alternative to the schemes in this Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison?

Ans. For UTI Focussed Equity Fund Series – 1 (2195 Days), investors can look at UTI Mutual Fund’s current open ended equity schemes. For Nippon India Capital Builder Fund IV Series A, Nippon India Mutual Fund offers other diversified equity schemes for investors seeking similar exposure today.

What risk category applies across the Nippon India Capital Builder Fund IV Series A vs UTI Focussed Equity Fund Series – 1 (2195 Days) comparison?

Ans. Nippon India Capital Builder Fund IV Series A is rated Moderately High risk. Close ended equity schemes like UTI Focussed Equity Fund Series – 1 (2195 Days) are typically also rated Very High risk.

News

Author: Ankit Jaiswal

Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.